EvlaBio
Pre-clinicalCreating innovative therapies for chronic kidney disease patients. Addressing left ventricular hypertrophy with monoclonal antibody treatments.
Founded
2021
Focus
AntibodiesBiologics
About
Creating innovative therapies for chronic kidney disease patients. Addressing left ventricular hypertrophy with monoclonal antibody treatments.
Company Info
TypePrivate
Founded2021
LocationLausanne, Switzerland
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
3Brain
Pre-clinical · Zug
Baxiva
Pre-clinical · Zug
AC Bioscience
Pre-clinical · Lausanne
Abrinca Genomics
Pre-clinical · Zurich
AdipoGen
Pre-clinical · Liestal
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile